Mark M Zalupski Selected Research

Mark M Zalupski Research Topics

Disease

33	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 05/2002
23	Neoplasms (Cancer) 04/2021 - 08/2002
11	Adenocarcinoma 01/2018 - 08/2002
7	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 01/2005
6	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 02/2004
4	Disease Progression 12/2018 - 05/2005
3	Carcinoma (Carcinomatosis) 04/2021 - 08/2007
3	Fatigue 06/2019 - 01/2013
3	Nausea 06/2019 - 01/2013
3	Neutropenia 08/2013 - 01/2005
3	Thrombocytopenia (Thrombopenia) 08/2013 - 01/2005
2	Diarrhea 06/2019 - 02/2004
2	Cholangiocarcinoma 12/2018 - 08/2015
2	Neoplasm Metastasis (Metastasis) 06/2015 - 08/2007
2	Cholangitis 01/2014 - 08/2013
2	Rectal Neoplasms (Rectal Cancer) 01/2013 - 08/2007
2	Weight Loss (Weight Reduction) 01/2013 - 02/2006
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2011 - 11/2002
1	Colonic Neoplasms (Colon Cancer) 12/2021
1	Vision Disorders (Hemeralopia) 12/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Rhinorrhea 06/2019
1	Dysarthria (Spastic Dysarthria) 06/2019
1	Paresthesia (Dysesthesia) 06/2019
1	Neurologic Manifestations (Neurological Manifestations) 06/2019
1	Flushing 06/2019
1	Exanthema (Rash) 02/2017
1	Vomiting 02/2017
1	Margins of Excision 08/2015
1	Carcinogenesis 06/2015
1	Klatskin Tumor 01/2014
1	Glioblastoma (Glioblastoma Multiforme) 06/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Thyroid Neoplasms (Thyroid Cancer) 06/2013
1	Mouth Neoplasms (Oral Cancer) 06/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2013
1	Dehydration (Water Stress) 01/2013
1	Asthenia 01/2013
1	Mucositis 01/2013

Drug/Important Bio-Agent (IBA)

33	Gemcitabine FDA Link 01/2020 - 05/2002
8	Capecitabine (Xeloda)FDA Link 08/2015 - 02/2004
7	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 05/2002
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 02/2004
6	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2002
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 02/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 02/2004
4	Ifosfamide FDA LinkGeneric 09/2015 - 02/2004
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2013
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2013
2	folfirinoxIBA 01/2020 - 06/2019
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 04/2009
2	Bevacizumab (Avastin)FDA Link 06/2019 - 01/2013
2	Drug CombinationsIBA 12/2018 - 02/2004
2	PlatinumIBA 12/2018 - 01/2018
2	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018 - 07/2010
2	HhAntag691IBA 12/2014 - 01/2013
2	Phosphotransferases (Kinase)IBA 06/2013 - 12/2011
2	CarbohydratesIBA 05/2013 - 01/2013
2	AntigensIBA 05/2013 - 01/2013
2	CreatinineIBA 12/2012 - 06/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012 - 01/2005
2	Imatinib Mesylate (Gleevec)FDA Link 12/2011 - 11/2002
2	Celecoxib (Celebrex)FDA Link 02/2008 - 12/2005
2	EnzymesIBA 02/2008 - 12/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2008 - 12/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2008 - 12/2005
2	Pharmaceutical PreparationsIBA 05/2005 - 05/2002
1	DNA (Deoxyribonucleic Acid)IBA 04/2021
1	RNA (Ribonucleic Acid)IBA 04/2021
1	pegfilgrastim (Neulasta)FDA Link 01/2020
1	adavosertibIBA 10/2019
1	Cholinergic Agents (Cholinergics)IBA 06/2019
1	Topoisomerase I InhibitorsIBA 06/2019
1	AlbuminsIBA 12/2018
1	Thymidylate SynthaseIBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 01/2018
1	PEGPH20IBA 01/2018
1	binimetinibIBA 02/2017
1	cabozantinibIBA 12/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 09/2015
1	Caveolin 1IBA 06/2015
1	AgarIBA 12/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014
1	ErbB Receptors (EGF Receptor)IBA 02/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2013
1	Cetuximab (Erbitux)FDA Link 02/2013
1	Monoclonal AntibodiesIBA 02/2013

Therapy/Procedure

29	Therapeutics 04/2021 - 05/2002
22	Radiotherapy 01/2020 - 05/2002
16	Drug Therapy (Chemotherapy) 06/2019 - 08/2002
6	Neoadjuvant Therapy 01/2018 - 02/2004
5	Chemoradiotherapy 10/2017 - 05/2002
3	Combination Drug Therapy (Combination Chemotherapy) 12/2009 - 01/2005
1	Adjuvant Chemotherapy 01/2016
1	Pancreaticoduodenectomy 10/2014
1	Liver Transplantation 01/2014